US Digital Therapeutics Market, Forecast to 2023

Digital therapeutics are about to become a true medical alternative that will utilize communications-based technologies, apps, and software to improve patient outcomes and help to lower the cost of healthcare. The overall digital therapeutics market is expected to grow at a compound annual growth rate of 30.7% from 2017 to 2023. This report emphasizes the importance of clearly defining the term "digital therapeutics." In many areas of the evolving healthcare market, an important facet of understanding opportunity and strategy is effective definition and scoping of new terminology and concepts. Frost & Sullivan reviews data that illustrate there is often an inconsistent definition of the term as well as the companies that are participating in this early market. The research reveals that there is a much smaller segment of the digital therapeutics market devoted to pure play participants that are developing true therapeutic solutions that will provide a medical-grade benefit to patients. The pure play market will require considerable research and development in partnership with pharmaceutical companies, and a US Food and Drug Administration certification for safety and efficacy after a clinical trial. Frost & Sullivan predicts that the digital therapeutics market will attract the interests of medical device companies, pharmaceutical industry participants, and investors. It is reasonable to foresee that several of the larger, established healthcare companies will carefully monitor progress in this space and make strategic moves as the smaller, new entrants demonstrate successful outcomes following randomized clinical trials.
Published: 25 May 2018

  1. Digital Therapeutics Market: Frost & Sullivan Research Methodology, US, 2018
  2. Total Digital Therapeutics Market: Market Engineering Measurements*, US, 2017
  3. Digital Health Market: Market Segmentation, Global, 2017
  4. Selected Telehealth/mHealth Markets with Highest Impact on Healthcare in the Next 5 Years, Top 2 Box, North America, 2014–2019
  5. Digital Therapeutics Market: Tech Roadmap, US, 2018–2025
  6. Total Digital Therapeutics Market: Market Segmentation, US, 2018
  7. Total Digital Therapeutics Market: Market Engineering Measurements, US, 2017
  8. Pure Play Digital Therapeutics Market: Revenue Forecast, US, 2017–2023
  9. Total Digital Therapeutics Market: Revenue Forecast, US, 2017–2023
  10. Total Digital Therapeutics Market: Revenue Forecast by Segment, US, 2017–2023
  11. Total Digital Therapeutics Market: Revenue Share by Segment, US, 2017
  12. Total Digital Therapeutics Market: Revenue Share Forecast by Segment, US, 2023
  13. Chronic Condition Management Segment: Revenue Forecast, US, 2017–2023
  14. Behavior Management Segment: Revenue Forecast, US, 2017–2023
  15. Medication Adherence Support Segment: Revenue Forecast, US, 2017–2023
  16. Data Gathering and Analytics Segment: Revenue Forecast, US, 2017–2023
  17. Digital Therapeutics Market: Select Market Participants by Tiers of Competition, US, 2018
  18. Digital Therapeutics Markets: Generic SWOT Analysis by Segment, US, 2018
  19. Total Digital Therapeutics Market: Professional-Consumer Spectrum, US, 2018

Features of this Research

Help Desk

Full list of offices


For more information and general enquiries, contact Frost & Sullivan near you.

North America
tel: +1.877.463.7678

Select a location near you..